Indian Journal of Pharmaceutical Education and Research logo
Submit
Indian Journal of Pharmaceutical Education and ResearchAn Official Publication of Association of Pharmaceutical Teachers of India (APTI)
Review

Prevalence and Pharmacotherapeutic Management of Pediatric Psoriasis–A Descriptive Review

1, 1, 1, 1

  1. 1Pharmacy Practice Research Unit, Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jizan, KSA.

CORRESPONDENCE

David Banji

Pharmacy Practice Research Unit, Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jizan, KSA.

davidbanji@gmail.com

Received: 02-04-2019; Accepted: 26-07-2019.

Volume 53, Issue 4 · pp. 569-576 · 2019 · DOI: 10.5530/ijper.53.4.118

ABSTRACT

Psoriasis is an auto-immune chronic inflammatory skin disease, which affects about 3.5% of the world’s population. Prevalence of psoriasis among children aged 0 to 18 years is 1% in the United State of America, 5.3% in eastern Saudi Arabia and is on constant rise in other parts of the world. An effective treatment of psoriasis in children may often be challenging mainly because of the lack of established therapeutic guidelines. The objective of this review, therefore, is to provide an update on the prevalence and the pharmacotherapeutic management of pediatric psoriasis, which could be beneficial to clinical pharmacists and other healthcare workers. This multifactorial papulosquamous disorder is linked with the genetic makeup of an individual although the various risk factors like obesity, stress, emotional imbalance, psychological disturbances, cold weather, skin irritation, infection in the respiratory tract and the presence of hemolytic streptococcus could trigger psoriasis. Plaque psoriasis is the most common; but, guttate, pustular disease, erythrodermic (red skin) and rheumatoid psoriasis diseases are also noticed in children. The successful approach for treating psoriasis in children depends on the precise selection of line of therapy on case-by-case basis to enhance benefit-risk ratio, with careful attention of its impact on the patient and family. Therefore, treatment of pediatric psoriasis must be rationalized based on the type and intensity of the disease to reduce probable side effects of drugs in children.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Albarraq, A. A., Alqahtani, S. S., Ahmad, S., & Banji, D. (2019). Prevalence and Pharmacotherapeutic Management of Pediatric Psoriasis–A Descriptive Review. Indian Journal of Pharmaceutical Education and Research, 53(4), 569-576. https://doi.org/10.5530/ijper.53.4.118

    Copyright and licence

    © 2019 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0